Description
An inhibitor of ApoE4 domain interactions (IC50 = 116 nM in a FRET reporter assay for amino- and carboxy-terminal domain interactions); restores intracellular trafficking of ApoE4 to the endoplasmic reticulum and Golgi apparatus in Neuro-2a cells expressing EGFP-ApoE4 or EGFP-ApoE4-R61T at 100 nM; restores levels of mitochondrial complex IV subunit 1 in Neuro-2a cells expressing ApoE4 (EC50 = 39 nM) and increases mitochondrial motility in neurons expressing ApoE4 (EC50 = <1 nM)
Formal name: 4-[[4-[[2-(3,4-dihydro-3-methyl-4-oxo-1-phthalazinyl)acetyl]amino]phenyl]methyl]-1-piperazinecarboxylic acid, 1,1-dimethylethyl ester
Synonyms:
Molecular weight: 491.6
CAS: 1311174-68-1
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Neuroscience|Neurodegenerative Disorders|Alzheimer’s Disease